Chiron IntraOptics announced on Monday that it has receivedFDA approval to market an expanded line of its Chiroflex IIsilicone foldable intraocular lenses (IOLs) used for cataractsurgery.

The products incorporate a modified C-loop used to fix the IOLin place, rather than the J-loop found in previously approvedChiroflex II lenses. The company estimates the C-loop marketat $100 million to $150 million.

"Market data shows that 48.5 percent of ophthalmic surgeonsprefer the modified C-loop configuration," said William J. Link,chairman and chief executive officer of the Irvine, Calif.,business unit of Chiron Corp. of Emeryville, Calif.

Product shipments will begin immediately, according to thecompany, which plans to offer both types of loops. -- HollyGanz

(c) 1997 American Health Consultants. All rights reserved.